Clinical Trial

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

Study acronym: REBOOT-PARADOX
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Aim of this study is to evaluate whether microsurgical repair or replacement of the aortic valve is a treatment option for a subgroup of patients suffering from aortic Stenosis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-03-04; most recent amendment 2025-04-30.
Status change: Recruiting → Active, Not Recruiting 2023-03-27
Status change: Not Yet Recruiting → Recruiting 2019-08-12
Trial Details
NCT Number NCT03863132
Lead Sponsor IHF GmbH - Institut für Herzinfarktforschung
Collaborators: Boston Scientific Group, Yale University
Conditions Aortic Valve Stenosis
Enrollment 120 participants
Start Date 2019-07-03
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-04